{"id":95979,"date":"2025-10-01T12:26:54","date_gmt":"2025-10-01T15:26:54","guid":{"rendered":"https:\/\/murray.adv.br\/?p=95979"},"modified":"2025-10-01T12:26:54","modified_gmt":"2025-10-01T15:26:54","slug":"novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes","status":"publish","type":"post","link":"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/","title":{"rendered":"Novo Nordisk, Eurofarma to jointly launch two drug brands for weight loss, diabetes"},"content":{"rendered":"<section class=\"content--header\">\n<div class=\"row content-head featured \">\n<div class=\"title\">\n<h6 class=\"content-head__title\" style=\"text-align: center\"><em><strong>Companies expect products to hit the Brazilian market in October<\/strong><\/em><\/h6>\n<\/div>\n<\/div>\n<div class=\"content__signa-share\">\n<div class=\"content__signature\">\n<div class=\"content-publication-data\">\n<div class=\"content-publication-data__text\">\n<div class=\"content-publication-data__from\"><\/div>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p class=\"content-publication-data__updated\">10\/01\/2025\u00a0<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"content__share-bar-container\">\n<div class=\"content__share-bar\"><\/div>\n<\/div>\n<\/div>\n<div class=\"row medium-uncollapsed content-top-image\" data-block-type=\"featured-image\" data-block-id=\"0\">\n<div class=\"column medium-centered medium-22 large-20 desktop \" style=\"text-align: center\">\n<figure class=\"content-featured-figure\"><img loading=\"lazy\" decoding=\"async\" class=\"content-featured-image aligncenter\" src=\"https:\/\/s2-valorinternational.glbimg.com\/_rcr4TGQmWuZTVAeLozjlNEyprA=\/0x0:5570x3713\/888x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_63b422c2caee4269b8b34177e8876b93\/internal_photos\/bs\/2023\/3\/z\/Wo4WXaTeCxBpGlrmyhjg\/pexels-ketut-subiyanto-4474052.jpg\" alt=\"Novo Nordisk, Eurofarma to jointly launch two drug brands for weight loss, diabetes\" width=\"5570\" height=\"3713\" \/><figcaption class=\"content-featured-caption\"><em>Novo Nordisk, Eurofarma to jointly launch two drug brands for weight loss, diabetes \u2014 Photo: Pexels<\/em><\/figcaption><\/figure>\n<\/div>\n<\/div>\n<\/section>\n<div id=\"mc-article-body\" class=\"mc-article-body \">\n<article>\n<div class=\"no-paywall\">\n<div class=\"mc-column mc-side-item__container\" data-block-type=\"ads\" data-block-id=\"1\"><\/div>\n<div class=\"mc-column content-text active-extra-styles active-capital-letter\" data-block-type=\"unstyled\" data-block-weight=\"47\" data-block-id=\"2\">\n<p class=\" content-text__container theme-color-primary-first-letter\" data-track-category=\"Link no Texto\" data-track-links=\"\" data-mrf-recirculation=\"Article links\">Danish pharmaceutical company\u00a0<strong>Novo Nordisk<\/strong>\u00a0and Brazil\u2019s\u00a0<strong>Eurofarma<\/strong>\u00a0announced on Wednesday (1) a partnership to launch two new brands of injectable biological semaglutide in Brazil for the treatment of obesity and diabetes. The companies said the medications are expected to reach the market as early as October.<\/p>\n<\/div>\n<div class=\"wall protected-content\">\n<div class=\"mc-column content-text active-extra-styles \" data-block-type=\"unstyled\" data-block-weight=\"46\" data-block-id=\"3\">\n<p class=\" content-text__container \" data-track-category=\"Link no Texto\" data-track-links=\"\" data-mrf-recirculation=\"Article links\">Under the agreement, Eurofarma will be the exclusive distributor responsible for the commercialization and promotion of the two weekly injectable semaglutide brands. One will be Poviztra, indicated for the treatment of obesity and overweight with associated comorbidities. The other, Extensior, will target type 2 diabetes treatment.<\/p>\n<\/div>\n<div class=\"mc-column content-text active-extra-styles \" data-block-type=\"unstyled\" data-block-weight=\"33\" data-block-id=\"4\">\n<p class=\" content-text__container \" data-track-category=\"Link no Texto\" data-track-links=\"\" data-mrf-recirculation=\"Article links\">\u201cThis partnership is a strategic step to ensure our innovation reaches even more people across Brazil,\u201d said Allan Finkel, vice president of Novo Nordisk Latam and Brazil, in a joint statement with Eurofarma.<\/p>\n<\/div>\n<div data-track-category=\"multicontent\" data-track-action=\"ultimo chunk conteudo\" data-track-noninteraction=\"false\" data-track-scroll=\"view\">\n<div class=\"mc-column content-text active-extra-styles \" data-block-type=\"unstyled\" data-block-weight=\"34\" data-block-id=\"5\">\n<p class=\" content-text__container \" data-track-category=\"Link no Texto\" data-track-links=\"\" data-mrf-recirculation=\"Article links\">Eurofarma\u2019s Brazil CEO, Renata Campos, said the company will leverage its sales expertise to expand the products\u2019 reach. \u201cA project that reflects a strong commitment to doctors and patients,\u201d she said in the statement.<\/p>\n<p data-track-category=\"Link no Texto\" data-track-links=\"\" data-mrf-recirculation=\"Article links\">*By\u00a0Michael Esquer\u00a0\u2014 S\u00e3o Paulo<\/p>\n<p data-track-category=\"Link no Texto\" data-track-links=\"\" data-mrf-recirculation=\"Article links\">Source: Valor International<\/p>\n<p>https:\/\/valorinternational.globo.com\/<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Companies expect products to hit the Brazilian market in October &nbsp; &nbsp; 10\/01\/2025\u00a0 Novo Nordisk, Eurofarma to jointly launch two drug brands for weight loss, diabetes \u2014 Photo: Pexels Danish pharmaceutical company\u00a0Novo Nordisk\u00a0and Brazil\u2019s\u00a0Eurofarma\u00a0announced on Wednesday (1) a partnership to launch two new brands of injectable biological semaglutide in Brazil for the treatment of obesity [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8106],"tags":[26469,16773,25702,26468],"class_list":["post-95979","post","type-post","status-publish","format-standard","hentry","category-murray-news","tag-diabetes-en","tag-eurofarma","tag-novo-nordisk","tag-to-jointly-launch-two-drug-brands-for-weight-loss"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Novo Nordisk, Eurofarma to jointly launch two drug brands for weight loss, diabetes - Murray Advogados<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novo Nordisk, Eurofarma to jointly launch two drug brands for weight loss, diabetes - Murray Advogados\" \/>\n<meta property=\"og:description\" content=\"Companies expect products to hit the Brazilian market in October &nbsp; &nbsp; 10\/01\/2025\u00a0 Novo Nordisk, Eurofarma to jointly launch two drug brands for weight loss, diabetes \u2014 Photo: Pexels Danish pharmaceutical company\u00a0Novo Nordisk\u00a0and Brazil\u2019s\u00a0Eurofarma\u00a0announced on Wednesday (1) a partnership to launch two new brands of injectable biological semaglutide in Brazil for the treatment of obesity [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/\" \/>\n<meta property=\"og:site_name\" content=\"Murray Advogados\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-01T15:26:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/s2-valorinternational.glbimg.com\/_rcr4TGQmWuZTVAeLozjlNEyprA=\/0x0:5570x3713\/888x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_63b422c2caee4269b8b34177e8876b93\/internal_photos\/bs\/2023\/3\/z\/Wo4WXaTeCxBpGlrmyhjg\/pexels-ketut-subiyanto-4474052.jpg\" \/>\n<meta name=\"author\" content=\"Gelcy Bueno\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gelcy Bueno\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/\"},\"author\":{\"name\":\"Gelcy Bueno\",\"@id\":\"https:\/\/murray.adv.br\/en\/#\/schema\/person\/dd0d0bea46c2436124555d18c1a0d52e\"},\"headline\":\"Novo Nordisk, Eurofarma to jointly launch two drug brands for weight loss, diabetes\",\"datePublished\":\"2025-10-01T15:26:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/\"},\"wordCount\":213,\"image\":{\"@id\":\"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/s2-valorinternational.glbimg.com\/_rcr4TGQmWuZTVAeLozjlNEyprA=\/0x0:5570x3713\/888x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_63b422c2caee4269b8b34177e8876b93\/internal_photos\/bs\/2023\/3\/z\/Wo4WXaTeCxBpGlrmyhjg\/pexels-ketut-subiyanto-4474052.jpg\",\"keywords\":[\"diabetes\",\"Eurofarma\",\"Novo Nordisk\",\"to jointly launch two drug brands for weight loss\"],\"articleSection\":[\"Murray News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/\",\"url\":\"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/\",\"name\":\"Novo Nordisk, Eurofarma to jointly launch two drug brands for weight loss, diabetes - Murray Advogados\",\"isPartOf\":{\"@id\":\"https:\/\/murray.adv.br\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/s2-valorinternational.glbimg.com\/_rcr4TGQmWuZTVAeLozjlNEyprA=\/0x0:5570x3713\/888x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_63b422c2caee4269b8b34177e8876b93\/internal_photos\/bs\/2023\/3\/z\/Wo4WXaTeCxBpGlrmyhjg\/pexels-ketut-subiyanto-4474052.jpg\",\"datePublished\":\"2025-10-01T15:26:54+00:00\",\"author\":{\"@id\":\"https:\/\/murray.adv.br\/en\/#\/schema\/person\/dd0d0bea46c2436124555d18c1a0d52e\"},\"breadcrumb\":{\"@id\":\"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/#primaryimage\",\"url\":\"https:\/\/s2-valorinternational.glbimg.com\/_rcr4TGQmWuZTVAeLozjlNEyprA=\/0x0:5570x3713\/888x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_63b422c2caee4269b8b34177e8876b93\/internal_photos\/bs\/2023\/3\/z\/Wo4WXaTeCxBpGlrmyhjg\/pexels-ketut-subiyanto-4474052.jpg\",\"contentUrl\":\"https:\/\/s2-valorinternational.glbimg.com\/_rcr4TGQmWuZTVAeLozjlNEyprA=\/0x0:5570x3713\/888x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_63b422c2caee4269b8b34177e8876b93\/internal_photos\/bs\/2023\/3\/z\/Wo4WXaTeCxBpGlrmyhjg\/pexels-ketut-subiyanto-4474052.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/murray.adv.br\/en\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novo Nordisk, Eurofarma to jointly launch two drug brands for weight loss, diabetes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/murray.adv.br\/en\/#website\",\"url\":\"https:\/\/murray.adv.br\/en\/\",\"name\":\"Murray Advogados\",\"description\":\"PLG International Lawyers\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/murray.adv.br\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/murray.adv.br\/en\/#\/schema\/person\/dd0d0bea46c2436124555d18c1a0d52e\",\"name\":\"Gelcy Bueno\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/murray.adv.br\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1ef2acfe966d6deacdeccd2a24ea89192c41fd05fc60e57b79021358a47f5641?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1ef2acfe966d6deacdeccd2a24ea89192c41fd05fc60e57b79021358a47f5641?s=96&d=mm&r=g\",\"caption\":\"Gelcy Bueno\"},\"url\":\"https:\/\/murray.adv.br\/en\/author\/news\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novo Nordisk, Eurofarma to jointly launch two drug brands for weight loss, diabetes - Murray Advogados","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/","og_locale":"en_US","og_type":"article","og_title":"Novo Nordisk, Eurofarma to jointly launch two drug brands for weight loss, diabetes - Murray Advogados","og_description":"Companies expect products to hit the Brazilian market in October &nbsp; &nbsp; 10\/01\/2025\u00a0 Novo Nordisk, Eurofarma to jointly launch two drug brands for weight loss, diabetes \u2014 Photo: Pexels Danish pharmaceutical company\u00a0Novo Nordisk\u00a0and Brazil\u2019s\u00a0Eurofarma\u00a0announced on Wednesday (1) a partnership to launch two new brands of injectable biological semaglutide in Brazil for the treatment of obesity [&hellip;]","og_url":"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/","og_site_name":"Murray Advogados","article_published_time":"2025-10-01T15:26:54+00:00","og_image":[{"url":"https:\/\/s2-valorinternational.glbimg.com\/_rcr4TGQmWuZTVAeLozjlNEyprA=\/0x0:5570x3713\/888x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_63b422c2caee4269b8b34177e8876b93\/internal_photos\/bs\/2023\/3\/z\/Wo4WXaTeCxBpGlrmyhjg\/pexels-ketut-subiyanto-4474052.jpg","type":"","width":"","height":""}],"author":"Gelcy Bueno","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Gelcy Bueno","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/#article","isPartOf":{"@id":"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/"},"author":{"name":"Gelcy Bueno","@id":"https:\/\/murray.adv.br\/en\/#\/schema\/person\/dd0d0bea46c2436124555d18c1a0d52e"},"headline":"Novo Nordisk, Eurofarma to jointly launch two drug brands for weight loss, diabetes","datePublished":"2025-10-01T15:26:54+00:00","mainEntityOfPage":{"@id":"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/"},"wordCount":213,"image":{"@id":"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/#primaryimage"},"thumbnailUrl":"https:\/\/s2-valorinternational.glbimg.com\/_rcr4TGQmWuZTVAeLozjlNEyprA=\/0x0:5570x3713\/888x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_63b422c2caee4269b8b34177e8876b93\/internal_photos\/bs\/2023\/3\/z\/Wo4WXaTeCxBpGlrmyhjg\/pexels-ketut-subiyanto-4474052.jpg","keywords":["diabetes","Eurofarma","Novo Nordisk","to jointly launch two drug brands for weight loss"],"articleSection":["Murray News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/","url":"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/","name":"Novo Nordisk, Eurofarma to jointly launch two drug brands for weight loss, diabetes - Murray Advogados","isPartOf":{"@id":"https:\/\/murray.adv.br\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/#primaryimage"},"image":{"@id":"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/#primaryimage"},"thumbnailUrl":"https:\/\/s2-valorinternational.glbimg.com\/_rcr4TGQmWuZTVAeLozjlNEyprA=\/0x0:5570x3713\/888x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_63b422c2caee4269b8b34177e8876b93\/internal_photos\/bs\/2023\/3\/z\/Wo4WXaTeCxBpGlrmyhjg\/pexels-ketut-subiyanto-4474052.jpg","datePublished":"2025-10-01T15:26:54+00:00","author":{"@id":"https:\/\/murray.adv.br\/en\/#\/schema\/person\/dd0d0bea46c2436124555d18c1a0d52e"},"breadcrumb":{"@id":"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/#primaryimage","url":"https:\/\/s2-valorinternational.glbimg.com\/_rcr4TGQmWuZTVAeLozjlNEyprA=\/0x0:5570x3713\/888x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_63b422c2caee4269b8b34177e8876b93\/internal_photos\/bs\/2023\/3\/z\/Wo4WXaTeCxBpGlrmyhjg\/pexels-ketut-subiyanto-4474052.jpg","contentUrl":"https:\/\/s2-valorinternational.glbimg.com\/_rcr4TGQmWuZTVAeLozjlNEyprA=\/0x0:5570x3713\/888x0\/smart\/filters:strip_icc()\/i.s3.glbimg.com\/v1\/AUTH_63b422c2caee4269b8b34177e8876b93\/internal_photos\/bs\/2023\/3\/z\/Wo4WXaTeCxBpGlrmyhjg\/pexels-ketut-subiyanto-4474052.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/murray.adv.br\/en\/novo-nordisk-eurofarma-to-jointly-launch-two-drug-brands-for-weight-loss-diabetes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/murray.adv.br\/en\/home\/"},{"@type":"ListItem","position":2,"name":"Novo Nordisk, Eurofarma to jointly launch two drug brands for weight loss, diabetes"}]},{"@type":"WebSite","@id":"https:\/\/murray.adv.br\/en\/#website","url":"https:\/\/murray.adv.br\/en\/","name":"Murray Advogados","description":"PLG International Lawyers","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/murray.adv.br\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/murray.adv.br\/en\/#\/schema\/person\/dd0d0bea46c2436124555d18c1a0d52e","name":"Gelcy Bueno","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/murray.adv.br\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1ef2acfe966d6deacdeccd2a24ea89192c41fd05fc60e57b79021358a47f5641?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1ef2acfe966d6deacdeccd2a24ea89192c41fd05fc60e57b79021358a47f5641?s=96&d=mm&r=g","caption":"Gelcy Bueno"},"url":"https:\/\/murray.adv.br\/en\/author\/news\/"}]}},"_links":{"self":[{"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/posts\/95979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/comments?post=95979"}],"version-history":[{"count":2,"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/posts\/95979\/revisions"}],"predecessor-version":[{"id":95981,"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/posts\/95979\/revisions\/95981"}],"wp:attachment":[{"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/media?parent=95979"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/categories?post=95979"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/murray.adv.br\/en\/wp-json\/wp\/v2\/tags?post=95979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}